Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4618398 | 0.81 | — | — | |
| SCHEMBL28933255 | 0.78 | — | — | |
| SCHEMBL42290 | 0.77 | — | — | |
| SCHEMBL16469538 | 0.77 | — | — | |
| SCHEMBL56129 | 0.77 | — | — | |
| SCHEMBL78983 | 0.74 | — | — | |
| SCHEMBL670979 | 0.74 | LMNA (0.46) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL21336455 | 0.74 | LMNA (0.46) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL386001 | 0.74 | LMNA (0.46) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL7535756 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | claimed |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS (US) | 2013-08-15 | — | — | US | claimed |
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | disclosed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | disclosed |
| CN-104854073-B | (6R, 10R) -6 prepared by 3,7- dimethyl-octa -2- olefine aldehydrs or bis- olefine aldehydr of 3,7- dimethyl-octa -2,6-, 10,14- trimethylpentadecane -2- ketone | 帝斯曼知识产权资产管理有限公司 | 2018-06-12 | — | — | CN | disclosed |
| CN-107922300-A | Method for preparing alpha-damascone | 巴斯夫欧洲公司 | 2018-04-17 | — | — | CN | disclosed |
| US-9809521-B2 | Cannabidinoid derivatives | SUTTER WEST BAY HOSPITALS (US) | 2017-11-07 | — | — | US | disclosed |
| CN-106463771-A | Gelated ionic liquid film coated surfaces and uses thereof | 格利恩技术私人有限公司 | 2017-02-22 | — | — | CN | disclosed |
| US-20160376211-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2016-12-29 | — | — | US | disclosed |
| CN-103957704-B | Microbicidal composition | 荷兰联合利华有限公司 | 2016-08-31 | — | — | CN | disclosed |
| CN-1778001-A | Method for controlling the molecular weight during poly(arylene vinylene) synthesis, and polymers produced therewith | COVION ORGANIC SEMICONDUCTORS (DE) | 2006-05-24 | — | — | CN | disclosed |
| EP-1631647-A1 | FUNCTIONALIZED POLYMER COMPOSITION FOR GREASE | THE LUBRIZOL CORPORATION (US) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004111163-A1 | FUNCTIONALIZED POLYMER COMPOSITION FOR GREASE | THE LUBRIZOL CORPORATION (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040254080-A1 | Functionalized polymer composition for grease | THE LUBRIZOL CORPORATION, A CORPORATION OF THE STATE OF OHIO (US) | 2004-12-16 | — | — | US | disclosed |
| EP-0369335-B1 | 2-Aminodecaline derivatives and their use | BASF AG (DE) | 1994-02-23 | — | — | EP | disclosed |
| US-5051409-A | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1991-09-24 | — | — | US | disclosed |
| US-5032616-A | Plants | TRACOR, INC. | 1991-07-16 | — | — | US | disclosed |
| EP-0369335-A2 | 2-Aminodecaline derivatives and their use | BASF Aktiengesellschaft (DE) | 1990-05-23 | — | — | EP | disclosed |
| EP-0258853-A1 | 4-Substituted cyclohexylamine derivatives, fungicides containing them and process for combating fungi | BASF Aktiengesellschaft (DE) | 1988-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | CNR1, CNR2, RCOR1 | LMNA 3370/4885BLM 1078/4885PTPN1 2991/4885 |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | CNR2, CNR1, GPR18 | LMNA 2282/4885BLM 3023/4885PTPN1 3988/4885 |
| US-20160376211-A1 | CANNABIDINOID DERIVATIVES | CNR2, CNR1, GPR18 | LMNA 2282/4885BLM 3023/4885PTPN1 3988/4885 |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | CNR1, CNR2, RCOR1 | LMNA 3370/4885BLM 1078/4885PTPN1 2991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.